Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Levodopa. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 9/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | EGFR | P00533 | 1/20 | 0.69 |
| ▸ | LCK | P06239 | 1/20 | 0.69 |
| ▸ | FYN | P06241 | 1/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | HTR2A | P28223 | 1/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.69 |
| ▸ | RECQL | P46063 | 1/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levodopa SCHEMBL896629 | 0.89 | SLC7A5 (0.87) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL27642065 | 0.89 | SLC7A5 (0.87) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Tyrosine SCHEMBL28049278 | 0.87 | SLC7A5 (0.69) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL5063603 | 0.86 | KDM6B (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL29429645 | 0.86 | KDM6B (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL8579024 | 0.85 | SLC7A5 (0.79) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL8579019 | 0.85 | SLC7A5 (0.79) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL245057 | 0.85 | SLC7A5 (0.90) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL245058 | 0.85 | SLC7A5 (0.90) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Levodopa SCHEMBL28214733 | 0.85 | SLC7A5 (0.90) | SLC7A5PTGS1KDM4EUSP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009037571-A2 | HEMOSTATIC MATERIAL CONTAINING SYNTHETIC PEPTIDES OR POLYSACCHARIDES | EHRLICH MIKE (DE) | 2009-03-26 | — | — | WO | disclosed |